We have to make sure that a patient with CML in the United
States is not penalized just for being in the United
States as opposed to, say, Korea, where the prices for the same CML drugs are about a third of what they are here," he said.
In the United States, medical costs have become a top cause of bankruptcy, and cancer is often the reason, he noted. A recent study found that the rate of bankruptcy among those with a cancer diagnosis is double that of the rate in the general population.